China NMPA Product Recall - Cardiac MRI image processing software

GE Medical Systems, LLC, through its Chinese entity GE Healthcare Systems Trade Development (Shanghai) Co., Ltd., initiated a voluntary recall of its Cardiac MRI Image Processing Software, version CardiacVX 1.1.0. This action was reported to the National Medical Products Administration (NMPA) on May 21, 2014, following an internal report dated May 16, 2014. The core issue identified was that when the "Magnitude weighting mask" option was selected during post-processing analysis of phase-contrast images, the software produced flow values that were inaccurately higher than the true values, potentially impacting clinical diagnosis. Although the product holds NMPA registration (CFDA (Imported) No. 20143700378), GE confirmed that no affected batches of the CardiacVX software were sold or distributed within China. Consequently, while a recall was announced to address the discrepancy, no physical product retrieval from the Chinese market was necessary. Provincial, autonomous region, and municipal food and drug administrations were advised by the NMPA to enhance supervision of similar medical device products.